Similarly, in diffuse large B cell lymphoma (DLBCL), patients demonstrated increased HGF and c-MET in their blood, bone marrow, plasma, and pleural fluid, which correlates with clinic outcomes (Tjin et al., 2006). The gene discussed is MET; the disease is diffuse large B-cell lymphoma.